Product NDC: | 55390-226 |
Proprietary Name: | Amikacin Sulfate |
Non Proprietary Name: | Amikacin Sulfate |
Active Ingredient(s): | 250 mg/mL & nbsp; Amikacin Sulfate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-226 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA063315 |
Marketing Category: | ANDA |
Start Marketing Date: | 19940531 |
Package NDC: | 55390-226-04 |
Package Description: | 10 VIAL in 1 BOX (55390-226-04) > 4 mL in 1 VIAL |
NDC Code | 55390-226-04 |
Proprietary Name | Amikacin Sulfate |
Package Description | 10 VIAL in 1 BOX (55390-226-04) > 4 mL in 1 VIAL |
Product NDC | 55390-226 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Amikacin Sulfate |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19940531 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | AMIKACIN SULFATE |
Strength Number | 250 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |